GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 800 shares, a decrease of 98.6% from the January 15th total of 58,800 shares. Based on an average daily volume of 5,800 shares, the short-interest ratio […]
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 66,800 shares, an increase of 14.8% from the November 30th total of 58,200 shares. Based on an average trading volume of 118,800 shares, the days-to-cover ratio is currently 0.6 […]
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report)’s share price dropped 5.4% during trading on Wednesday . The company traded as low as $0.29 and last traded at $0.30. Approximately 109,688 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 303,826 shares. The stock had previously closed at […]
GT Biopharma (NASDAQ:GTBP – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a report issued on Tuesday, Benzinga reports. They currently have a $5.00 price target on the stock. HC Wainwright also issued estimates for GT Biopharma’s Q3 2023 earnings at ($0.10) EPS, Q4 2023 earnings at […]
GT Biopharma, Inc (NASDAQ:GTBP) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.